The oncology segment is expected to exceed USD 46.5 billion by 2028. This is owing to the rising incidence of cancer. This has also prompted sponsors to invest in developing new drugs and medical devices to treat the disease.

This segment is expected to grow at a fast rate over the forecast period. The oncology segment of the What is a CRO market has several players. The report covers details on the competition and recent developments.

It also includes trade regulations, import-export analysis, production analysis, value chain optimization, and emerging revenue pockets. Additionally, it includes information on product approvals, geographic expansions, and technological innovations. North America is the largest market for contract research organizations.

The region boasts a high density of pharmaceutical companies and a significant growth potential. Furthermore, the growing prevalence of certain cancers, such as gastric cancer, will spur enrollment for oncology clinical trials. Moreover, studies conducted in the region may shed light on various risk factors for cancer in different geographic regions and contribute to target discovery.

The market for contract research organizations in the oncology segment is expected to grow at a high rate over the next five years. The segment will be driven by the increasing incidence of chronic diseases and the increasing need for timely and accurate disease diagnosis.